BMJ : British medical journal
-
Randomized Controlled Trial Multicenter Study Comparative Study Clinical Trial
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis.
To assess the safety and efficacy of etoricoxib, a selective cyclo-oxygenase-2 inhibitor, in comparison with indometacin in the treatment of acute gouty arthritis. ⋯ Etoricoxib 120 mg once daily provides rapid and effective treatment for acute gouty arthritis comparable to indometacin 50 mg three times daily. Etoricoxib was generally safe and well tolerated in this study.